MALVERN, PA — Neuronetics Inc. (Nasdaq: STIM) said Executive Vice President, Chief Financial Officer and Treasurer Steven E. Pfanstiel will leave the company, with his departure effective May 1, 2026, as he pursues another opportunity.
Pfanstiel will remain with the company through his departure date to support a transition, and his resignation is not related to any disagreement with management or the board, according to the company.
Neuronetics said it has begun a search for a successor.
The company also reaffirmed the financial guidance it issued during its fourth-quarter 2025 earnings call on March 17, 2026.
Neuronetics develops and markets medical technology for neurohealth disorders, including its NeuroStar Advanced Therapy system, a noninvasive treatment for major depressive disorder and other conditions.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.